NCT05045560

Brief Summary

Objective : Anorectal malformations (ARMs) are part of a spectrum of malformations due to an abnormal separation between the urogenital and digestive tracts during embryonic life. The prevalence of ARM is 1/2000 - 1/5000 live births, making it a relatively common malformation. The impact of an ARM depends mainly on the type of malformation, which can be difficult to evaluate in the antenatal period, and whether it is isolated or associated (50-80%) with other malformations or genetic syndromes. Only 1 to 16% of ARMs are diagnosed in the antenatal period. The objective of this study is to compare cases of prenatal diagnosis of ARM, cases of postnatal diagnosis of ARM with other antenatal ultrasound abnormalities, and those with normal antenatal ultrasound, in terms of management and functional prognosis, to identify ways to improve prenatal counseling. Materials and methods : In this retrospective monocentric study, the investigators have included all fetuses and newborns born between January 2010 and September 2020 with anorectal malformations, diagnosed from postnatal radiological examinations and surgical or autopsy reports at the University Hospital of Montpellier. The Krickenbeck classification was used to classify the ARMs and to assess the functional prognosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
11.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2021

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 6, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 16, 2021

Completed
Last Updated

September 21, 2021

Status Verified

September 1, 2021

Enrollment Period

11.6 years

First QC Date

September 6, 2021

Last Update Submit

September 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of ante or post-natal diagnosispremolars

    Number of ante or post-natal diagnosis

    1 day

Secondary Outcomes (1)

  • Number of with or without associated antenatal anomalies

    1 day

Study Arms (3)

antenatal diagnosis of anorectal malformation

Groupe 1 : antenatal diagnosis of anorectal malformation

postnatal diagnosis of anorectal malfiormation with associated anomalies on antenatal ultrasound

Groupe 2 : postnatal diagnosis of anorectal malfiormation with associated anomalies on antenatal ultrasound

postnatal diagnosis of anorectal malformation with anormal antenatal ultrasound

Groupe 3 : postnatal diagnosis of anorectal malformation with anormal antenatal ultrasound

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all fetuses and newborns born between January 2010 and September 2020 with anorectal malformations, diagnosed from postnatal radiological examinations and surgical or autopsy reports at the University Hospital of Montpellier.

You may qualify if:

  • fetuses and newborns born between January 2010 and September 2020 with anorectal malformations
  • diagnosed from postnatal radiological examinations and surgical or autopsy reports at the University Hospital of Montpellier.

You may not qualify if:

  • foreign-born patient
  • anorectal malformation associated with an abdominal wall defect

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

Biospecimen

Retention: NONE RETAINED

NC

MeSH Terms

Conditions

Anorectal Malformations

Condition Hierarchy (Ancestors)

Digestive System AbnormalitiesDigestive System DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Florent Fuchs, MD; PHD

    University Hospital, Montpellier

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2021

First Posted

September 16, 2021

Study Start

January 1, 2010

Primary Completion

August 1, 2021

Study Completion

August 30, 2021

Last Updated

September 21, 2021

Record last verified: 2021-09

Locations